An industrial city's health department is planning an intervention to completely eliminate occupational exposure to a specific aerosolized solvent. Historical data show that 30% of the city's adult residents are exposed to this solvent at their workplaces. Extensive cohort studies have demonstrated that the relative risk of developing a severe demyelinating neuropathy in exposed residents compared to unexposed residents is . The baseline annual incidence of this neuropathy in the unexposed population is cases per people.
Assuming the intervention successfully reduces exposure to zero with an immediate effect on risk, and the population size remains stable, how many incident cases of this neuropathy will be prevented per residents in the first year?
Answer: 300 cases